Table 4.
Treatment-emergent adverse events and overall tolerability
| TEAEs throughout the study >2%, n (%) | |
|---|---|
| Total number of patients | 46 (39.7) |
| Akathisia | 15 (12.9) |
| Anxiety | 12 (10.3) |
| Parkinsonism | 7 (6.0) |
| Dizziness | 4 (3.5) |
| Lethargy | 4 (3.5) |
| Insomnia | 3 (2.6) |
| Sleep disorder | 3 (2.6) |
| Physicians’ impression about overall tolerability, n (%) | |
| Very satisfied | 52 (44.8) |
| Satisfied | 45 (38.8) |
| Neutral | 5 (4.3) |
| Dissatisfied | 12 (10.3) |
| Very dissatisfied | 2 (1.7) |
TEAEs, treatment-emergent adverse events.